DIMERIX LTD ORDINARY (DXB) Short Interest

Name: DIMERIX LTD ORDINARY (DXB) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

DIMERIX LTD ORDINARY (ASX:DXB) had 0.03% of shares reported as short positions as of 4 June 2026, representing 186,637 shares. DIMERIX LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.03%
Reported positions: 186,637
Industry: Pharmaceuticals, Biotechnology & Life Sciences
As of: 4 June 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

DXB

Dimerix

Pharmaceuticals, Biotechnology & Life Sciences

Dimerix is a clinical-stage biopharmaceutical company leveraging its proprietary Receptor-HIT platform to develop patient-preferred pharmaceutical products for global markets. Their focus is on identifying and developing drugs for areas with unmet needs, particularly in inflammatory diseases affecting the kidney and lungs.

biopharmaceutical

clinical stage

receptor-HIT

kidney disease

Shorted

short percentage0.03%

reported shorts186.6K

shares on issue600.397M